1
|
Jayne DRW, Bruchfeld A, Schaier M, Ciechanowski K, Harper L, Jadoul M, Segelmark M, Selga D, Szombati I, Venning M, Hamilton P, Hugo C, Van Daele PLA, Viklicky O, Potarca A, Schall TJ, Bekker P, Loirat C, Legendre CM, Ogawa M, Bedrosian CL, Kincaid JF, Fakhouri F, Guillevin L, Karras A, Pagnoux C, Carron PL, Quemeneur T, Gobert P, Daugas E, Mouthon L, Whatmough S, Fernandez S, Sweeney N, Dhaygude A, Rathi M, Goyal A, Gupta PK, Jaryal A, Sharma A, Jha V, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Sakhuja V. GLOMERULONEPHRITIDES. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu120] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
2
|
Monova D, Monov S, Todorov T, Soderberg D, Kurz T, Weiner M, Eriksson P, Segelmark M, Jakuszko K, Sebastian A, Bednarz Z, Krajewska M, Wiland P, Madziarska K, Weyde W, Klinger M, Naidoo J, Wearne N, Jones E, Swanepoel C, Rayner B, Okpechi I, Endo N, Tsuboi N, Furuhashi K, Matsuo S, Maruyama S, Clerte M, Levi C, Touzot M, Fakhouri F, Monge C, Lebas C, Abboud I, Huart A, Durieux P, Charlin E, Thervet E, Karras A, Smykal-Jankowiak K, Niemir ZI, Polcyn-Adamczak M, Whatmough S, Sweeney N, Fernandez S, Hussain M, Dhaygude A, Jakuszko K, Bednarz Z, Sebastian A, Krajewska M, Gniewek K, Wiland P, Weyde W, Klinger M, Manenti L, Urban ML, Vaglio A, Gintoli E, Galletti M, Buzio C, Monova D, Monov S, Argirova T, Wong I, Ibrahim FH, Goh BL, Lim TS, Chan MW, Hiramtasu R, Ubara Y, Hoshino J, Takaichi K, Ghafoor V, Hussain M, Dhaygude A, Whatmough S, Fernandez S, Sweeney N, Hussain M, Dhaygude A, Sahay M, Soma J, Nakaya I, Sasaki N, Yoshikawa K, Sato H, Kaminskyy V, ZAbi Ska M, Krajewska M, Ko Cielska-Kasprzak K, Jakuszko K, Klinger M, Niemir Z, Wozniczka K, Swierzko A, Cedzynski M, Polcyn-Adamczak M, Sokolowska A, Szala A, Arjunan A, Mikhail A, Shrivastava R, Parker C, Aithal S, Gursu M, Ozari M, Yucetas E, Sumnu A, Doner B, Cebeci E, Ozkan O, Aktuglu MB, Karaali Z, Koldas M, Ozturk S, Marco H, Picazo M, Da Silva I, Gonzalez A, Arce Y, Gracia S, Corica M, Llobet J, Diaz M, Ballarin J, Schonermarck U, Hagele H, Baumgartner A, Fischereder M, Muller S, Oliveira CBL, Oliveira ASA, Carvalho CJB, Pessoa CTBC, Sette LHBC, Fernandes GV, Cavalcante MAGM, Valente LM, Wan Q, Hu H, He Y, Li T, Aazair N, Houmaid Z, Rhair A, Bennani N, Demin A, Petrova O, Kotova O, Demina L, Roccatello D, Sciascia S, Rossi D, Naretto C, Baldovino S, Alpa M, Salussola I, Modena V, Zakharova EV, Vinogradova OV, Stolyarevich ES, Yap DYH, Chan TM, Thanaraj V, Dhaygude A, Ponnusamy A, Pillai S, Argentiero L, Schena A, Rossini M, Manno C, Castellano G, Martino M, Mitrotti A, Giliberti M, Digiorgio C, Di Palma AM, Battaglia M, Ditonno P, Grandaliano G, Gesualdo L, Oliveira CBL, Carvalho CJB, Oliveira ASA, Pessoa CTBC, Sette LHBC, Fernandes GV, Cavalcante MAGM, Valente LM, Neprintseva N, Tchebotareva N, Bobkova I, Kozlovskaya L, Rabrenovi V, Kova Evi Z, Jovanovi D, Rabrenovi M, Anti S, Ignjatovi L, Petrovi M, Longhi S, Del Vecchio L, Vigano S, Casartelli D, Bigi MC, Corti M, Limardo M, Tentori F, Pontoriero G, Zeraati AA, Shariati Sarabi Z, Davoudabadi Farahani A, Mirfeizi Z, Bae E. PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 2. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Lee A, McVey J, Faustino P, Lute S, Sweeney N, Pawar V, Khan M, Brorson K, Hussong D. Use of Hydrogenophaga pseudoflava penetration to quantitatively assess the impact of filtration parameters for 0.2-micrometer-pore-size filters. Appl Environ Microbiol 2010; 76:695-700. [PMID: 19966023 PMCID: PMC2812990 DOI: 10.1128/aem.01825-09] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2009] [Accepted: 11/23/2009] [Indexed: 11/20/2022] Open
Abstract
Filters rated as having a 0.2-microm pore size (0.2-microm-rated filters) are used in laboratory and manufacturing settings for diverse applications of bacterial and particle removal from process fluids, analytical test articles, and gasses. Using Hydrogenophaga pseudoflava, a diminutive bacterium with an unusual geometry (i.e., it is very thin), we evaluated passage through 0.2-microm-rated filters and the impact of filtration process parameters and bacterial challenge density. We show that consistent H. pseudoflava passage occurs through 0.2-microm-rated filters. This is in contrast to an absence of significant passage of nutritionally challenged bacteria that are of similar size (i.e., hydrodynamic diameter) but dissimilar geometry.
Collapse
Affiliation(s)
- A. Lee
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - J. McVey
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - P. Faustino
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - S. Lute
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - N. Sweeney
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - V. Pawar
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - M. Khan
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - K. Brorson
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| | - D. Hussong
- Office of Biotechnology Products, Office of Pharmaceutical Science New Drug Microbiology Staff, Office of Generic Drugs, Office of Testing and Research, U.S. Food and Drug Administration, Silver Spring, Maryland
| |
Collapse
|